CClinicalTrials.gg
Status unknownNCT00164918Updated Sep 14, 2005

Role of Routine Nasogastric Decompression After Subtotal Gastrectomy

A Phase 3 interventional study of nasogastric tube in Cancer of Stomach, sponsored by Chinese University of Hong Kong. Status unknown at 1 site in China. Open to participants aged 18 Weeks and older. Per ClinicalTrials.gov, last updated 2005-09-14.

Sponsored by Chinese University of Hong Kong · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2005), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 3
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Weeks and older
Sex
All
01

Study summary

The aim of the study is to evaluate whether subtotal gastrectomy without post-operative nasogastric decompression is better in terms of early post-operative bowel function and chest complication.

Read the detailed description

Nasogastric decompression is an intra-operative routine in most of the time to facilitate exposure of operative field during elective subtotal gastrectomy, but whether it should be retained post-operatively is controversial. Nasogastric decompression helps to drain the gastric remnant in case there is edema around the gastrojejunostomy, ileus and delayed gastric emptying, which can theoretically relieve nausea and abdominal distension. Besides, it may help decrease diaphragmatic splintage and hence decrease chance of chest infection if ileus occurs. However, nasogastric intubation could cause patient discomfort; also it has been shown that it would cause gastroesophageal reflux which may be associated with chest complication. There have been studies showing that routine post-operative nasogastric decompression is not necessary for gastrectomy in general, but the role in subtotal gastrectomy for stomach cancer is not well defined.

02

Conditions studied

  • Cancer of Stomach

Browse trials for

03

In context

Stomach Neoplasms

2,851 studies on the registry are indexed under Stomach Neoplasms; 864 are open to participants now.

This study's enrollment of 90 is above the median of 67 across 2,096 interventional studies indexed under Stomach Neoplasms.

Browse Stomach Neoplasms studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Weeks and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:All patients suffering from carcinoma of stomach, decided for operation

  • subtotal, D1/D2 dissection
  • palliative resection

Exclusion Criteria:

  • actively bleeding tumor
  • perforation of tumor
  • patient present with gastric outlet obstruction
  • combine organ excision
  • known diabetes with nephropathy
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants

Interventions

  • Devicenasogastric tube
06

What researchers measure

Primary outcomes

  1. Bowel function and related symptoms early post-op

07

Study locations

1 of 1 sites recruiting
  • Surgical Ward, Prince of Wales Hospital
    Hong Kong, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2005, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00164918
Lead sponsor
Chinese University of Hong Kong
First posted
Sep 14, 2005
Start date
Sep 2004
Last update
Sep 14, 2005

Study contacts

Enders K. W. Ng, MD
Contact
endersng@surgery.cuhk.edu.hk
85226322627
Man Yee Yung, BN
Contact
myyung@surgery.cuhk.edu.hk
85226322956
Enders K.W. Ng, MD
principal investigator · Chinese University of Hong Kong
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion